SNAP Update and ResourcesActualización y recursos de SNAP
On November 1, 2025, the requirements to receive and apply to the Supplemental Nutrition Assistance Program (SNAP) benefits have changed. To see the new policies to request SNAP benefits, click here and/or call 211 for SNAP assistance. Learn more
El 1 de noviembre de 2025, cambiaron los requisitos para recibir y aplicar para los beneficios del Programa de Asistencia Nutricional Suplementaria (SNAP, por sus siglas en inglés). Para consultar las nuevas políticas para aplicar para los beneficios de SNAP, haz clic aquí o llama al 211 para obtener ayuda de SNAP. Aprende Más
Transportation UpdateActualización de transporte
Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.
For other questions, please call Member Services at the number on the back of your member ID card.
A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).
Alert Provider! Change in PDL Status for the Smoking Cessation Drug Class Effective May 16, 2023
Date: May 18, 2023
Attention: All Providers
Effective Date: May 16, 2023
Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective May 16, 2023, Texas Health and Human Services Commission (HHSC) removed non-preferred status from the generic product, varenicline, to the preferred drug list (PDL). The preferred status of the brand product Chatnix® (NDC 00069-0468-56, 00069-0471-03, 00069-0469-56) will not change. This is in response to drug shortage for the brand Chantix® due to a manufacturing delay of this product by Pfizer.
Please see below the NDCs for varenicline that will be recognized as PDL
How this impacts providers: The change will allow prescribers to prescribe the generic vareniciline without requiring PDL prior authorization at this time. Providers will be able to continue providing necessary medication to their members.
Next steps for providers: Prescribers are encouraged to proactively obtain a prescription for the alternative preferred varenicline to avoid disruption in patient’s therapy. Prescribers should share this communication with their staff.
NOTE: This change is temporary. HHSC will further assess the availability of any alternative brand name products for smoking cessation. HHSC will also provide further announcements regarding future PDL status changes when information comes available.
